📰 Lenvima Keytruda News
Lenvima Keytruda News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lenvima Keytruda. Real-time updates on events, politics, business and more.
July 16, 2023
Long-term follow-up data showed that Lenvima plus Keytruda continued to show benefit in patients with metastatic kidney cancer.
June 6, 2023
After a median follow-up of four years, the survival benefit, including progression-free survival persisted in patients with advanced clear cell renal cell carcinoma treated with Lenvima plus Keytruda compared with those treated with Sutent.
June 6, 2023
Longer follow-up data showed that Lenvima plus Keytruda still outperformed Sutent in the treatment of patients with advanced renal cell carcinoma.